Complete Filing Data
BioScience Health Innovations, Inc. reported Stockholders Equity of $1.48 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean BioScience Health Innovations, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income Loss | $642.1K | $87.0K | -$251.5K | -$170.5K | -$25.6K | -$7.7K |
| Revenues | $5.7M | $1.8M | $597.6K | $69.3K | $0.00 | $0.00 |
| Operating Income Loss | $719.1K | $87.0K | -$251.5K | -$170.5K | -$25.6K | -$7.7K |
| Selling General And Administrative Expense | $2.2M | $1.1M | $706.3K | $151.3K | $25.6K | $7.7K |
| Operating Expenses | $2.5M | $1.2M | $735.9K | $230.1K | $25.6K | $7.7K |
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $3.2M | $1.3M | $484.4K | $59.6K | ||
| Cost Of Goods And Services Sold | $2.4M | $536.1K | $113.2K | $9.7K | ||
| Income Tax Expense Benefit | $77.0K | $0.00 | $0.00 | $0.00 | $0.00 | |
| General And Administrative Expense | $7.7K | |||||
| Deferred Revenue Current | $136.6K | $24.3K | $3.9K | $0.00 | ||
| Other Nonoperating Income Expense | $8.7K | $0.00 | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$83.2K | -$25.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$8.8K | $457.7K | $426.8K | $56.2K | $74.2K | -$53.4K | -$57.1K | -$85.3K | -$70.7K | -$28.9K | -$84.7K | -$1.9K | -$4.2K | -$14.1K | -$3.2K | -$12.7K | -$5.6K | -$2.9K | -$1.9K | $0.00 | -$900.00 |
| Revenues | $1.1M | $1.8M | $1.2M | $573.0K | $384.2K | $277.6K | $192.2K | $69.5K | $32.3K | $0.00 | $19.7K | $8.0K | $279.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income Loss | -$8.8K | $457.7K | $426.8K | $56.2K | $74.2K | -$53.4K | -$57.1K | -$85.3K | -$70.7K | -$28.9K | -$84.7K | -$1.9K | -$4.2K | -$14.1K | -$3.2K | -$12.7K | -$5.6K | -$2.9K | -$1.9K | $0.00 | -$900.00 |
| Selling General And Administrative Expense | $576.7K | $540.1K | $433.6K | $345.3K | $222.7K | $278.3K | $210.3K | $138.7K | $92.3K | $28.9K | $94.1K | $8.4K | $150.00 | $14.1K | $3.2K | $12.7K | $5.6K | ||||
| Operating Expenses | $707.0K | $616.8K | $469.3K | $368.5K | $236.2K | $288.1K | $217.5K | $145.2K | $98.3K | $28.9K | $101.1K | $8.9K | $4.4K | $14.1K | $3.2K | $12.7K | $5.6K | ||||
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Gross Profit | $698.2K | $1.1M | $896.1K | $424.7K | $310.4K | $234.8K | $160.3K | $60.0K | $27.6K | $16.4K | $7.1K | $214.00 | |||||||||
| Cost Of Goods And Services Sold | $433.2K | $683.0K | $330.9K | $148.2K | $73.8K | $42.8K | $31.8K | $9.5K | $4.7K | $3.3K | $982.00 | $65.00 | |||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| General And Administrative Expense | $3.2K | $12.7K | $5.6K | $2.9K | $1.9K | $0.00 | $900.00 | ||||||||||||||
| Deferred Revenue Current | $111.0K | $248.7K | $50.0K | $0.00 | $0.00 | ||||||||||||||||
| Other Nonoperating Income Expense | $0.00 | $8.7K | $0.00 | $0.00 | |||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$47.9K | -$17.5K | -$3.2K | -$12.7K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.5M | $835.2K | -$6.8K | -$17.2K | -$1.0K | $12.8K | $1.9K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $661.9K | $662.5K | $19.2K | $11.6K | $100.00 | $20.6K | |
| Retained Earnings Accumulated Deficit | $301.0K | -$341.1K | -$428.1K | -$176.6K | -$34.2K | -$8.6K | -$900.00 |
| Liabilities And Stockholders Equity | $1.7M | $873.8K | $93.4K | $31.6K | $6.3K | $20.6K | $1.9K |
| Common Stock Value | $1.1K | $4.4K | $4.1K | $546.00 | $546.00 | $546.00 | $280.00 |
| Assets | $1.7M | $873.8K | $93.4K | $31.6K | $6.3K | $20.6K | $1.9K |
| Cash And Cash Equivalents At Carrying Value | $661.9K | $662.5K | $19.2K | $11.6K | $0.00 | ||
| Liabilities | $229.9K | $38.5K | $100.1K | $48.8K | $19.1K | $7.8K | $0.00 |
| Accounts Payable Current | $6.3K | $8.2K | $7.7K | $3.4K | $0.00 | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$592.00 | $643.3K | $7.7K | $11.5K | -$18.6K | ||
| Preferred Stock Value | $14.00 | $14.00 | $14.00 | $14.00 | $0.00 | ||
| Assets Current | $1.6M | $847.8K | $93.4K | $31.6K | $6.3K | $20.6K | |
| Cash | $661.9K | $662.5K | $19.2K | $11.6K | $0.00 | ||
| Repayments Of Related Party Debt | $3.2M | $1.1M | $572.3K | $134.4K | |||
| Inventory Net | $336.3K | $58.3K | $37.7K | $12.3K | |||
| Accounts Receivable Net Current | $399.3K | $100.3K | $36.4K | $7.8K | |||
| Accrued Liabilities Current | $8.0K | $6.0K | $1.5K | $0.00 | |||
| Gains Losses On Extinguishment Of Debt | $8.7K | $0.00 | |||||
| Intangible Assets Net Excluding Goodwill | $82.9K | $26.0K | $0.00 | ||||
| Cash And Cash Equivalents Period Increase Decrease | -$18.6K | $20.6K | |||||
| Other Receivables Net Current | $137.7K | $21.8K | $0.00 | ||||
| Notes Payable Related Parties Classified Current | $0.00 | $7.1K | $0.00 | ||||
| Loans Payable Current | $0.00 | $8.7K | $760.00 | ||||
| Interest Payable Current | $0.00 | $450.00 | $0.00 | ||||
| Deferred Offering Costs | $0.00 | $1.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.7M | $1.7M | $1.3M | $370.3K | $189.1K | $114.9K | $8.6K | -$54.3K | -$89.0K | $25.5K | -$37.5K | -$2.8K | -$944.00 | $73.1K | -$12.8K | -$8.6K | -$5.4K | $7.2K | -$15.7K | -$26.00 | $1.9K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.1M | $1.3M | $1.0M | $333.2K | $143.9K | $92.9K | $42.0K | $30.3K | $9.5K | $28.3K | $7.5K | $8.2K | $1.1K | $96.1K | $2.0K | $374.00 | $2.4K | ||||||
| Retained Earnings Accumulated Deficit | $534.6K | $543.4K | $85.7K | -$351.0K | -$407.2K | -$481.5K | -$389.7K | -$332.6K | -$247.3K | -$146.3K | -$117.4K | -$113.7K | -$65.8K | -$48.3K | -$30.0K | -$26.8K | -$14.2K | -$5.7K | -$2.8K | -$900.00 | |||
| Liabilities And Stockholders Equity | $2.1M | $2.1M | $1.4M | $415.8K | $213.6K | $154.8K | $95.0K | $63.0K | $27.4K | $28.3K | $16.3K | $24.5K | $71.1K | $96.1K | $374.00 | $2.4K | $20.1K | $22.9K | $7.9K | $8.0K | |||
| Common Stock Value | $1.1K | $4.4K | $4.4K | $4.2K | $4.2K | $4.2K | $4.1K | $4.0K | $4.0K | $546.00 | $546.00 | $546.00 | $546.00 | $546.00 | $546.00 | $546.00 | $546.00 | $546.00 | $307.00 | $280.00 | |||
| Assets | $2.1M | $2.1M | $1.4M | $415.8K | $213.6K | $154.8K | $95.0K | $63.0K | $27.4K | $28.3K | $16.3K | $24.5K | $71.1K | $96.1K | $374.00 | $2.4K | $20.1K | $22.9K | $7.9K | $8.0K | |||
| Cash And Cash Equivalents At Carrying Value | $1.1M | $1.3M | $1.0M | $333.2K | $143.9K | $92.9K | $42.0K | $30.3K | $9.5K | $96.1K | $2.0K | $374.00 | $2.4K | $20.1K | $20.6K | $22.9K | $2.6K | $0.00 | |||||
| Liabilities | $356.1K | $337.6K | $132.9K | $45.5K | $24.5K | $39.9K | $86.4K | $116.4K | $2.9K | $1.9K | $16.7K | $15.5K | $23.0K | $9.0K | $7.8K | $12.8K | $7.2K | $8.0K | $6.1K | ||||
| Accounts Payable Current | $10.2K | $16.6K | $16.4K | $8.4K | $7.0K | $4.2K | $8.0K | $901.00 | $15.2K | $2.9K | $1.9K | $6.4K | $4.7K | $3.3K | $760.00 | $760.00 | $760.00 | $760.00 | $760.00 | $1.8K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $365.8K | $73.7K | -$2.1K | $12.1K | $956.00 | $94.1K | |||||||||||||||||
| Preferred Stock Value | $14.00 | $14.00 | $14.00 | $14.00 | $14.00 | $14.00 | $14.00 | $14.00 | $14.00 | $14.00 | $10.00 | $10.00 | $10.00 | $10.00 | |||||||||
| Assets Current | $2.0M | $2.0M | $1.3M | $408.8K | $213.6K | $154.8K | $95.0K | $63.0K | $27.4K | $28.3K | $16.3K | $24.5K | $71.1K | ||||||||||
| Cash | $1.1M | $1.3M | $1.0M | $333.2K | $143.9K | $92.9K | $42.0K | $30.3K | $9.5K | $96.1K | $2.0K | $374.00 | $2.4K | $20.1K | $20.6K | $22.9K | $2.6K | $0.00 | |||||
| Repayments Of Related Party Debt | $522.0K | $286.1K | $18.0K | $0.00 | |||||||||||||||||||
| Inventory Net | $757.5K | $248.5K | $215.7K | $42.2K | $40.6K | $40.4K | $34.3K | $15.8K | $14.1K | ||||||||||||||
| Accounts Receivable Net Current | $63.2K | $390.0K | $93.4K | $31.9K | $27.6K | $21.4K | $18.7K | $15.8K | $3.8K | ||||||||||||||
| Accrued Liabilities Current | $6.7K | $24.5K | $20.8K | $2.5K | $2.0K | $1.9K | $5.0K | $0.00 | |||||||||||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | $8.7K | $0.00 | $0.00 | ||||||||||||||||||
| Intangible Assets Net Excluding Goodwill | $72.1K | $72.1K | $56.0K | $7.0K | |||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | $94.1K | -$578.00 | $0.00 | $0.00 | |||||||||||||||||||
| Other Receivables Net Current | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||
| Notes Payable Related Parties Classified Current | $7.1K | $7.1K | $7.1K | ||||||||||||||||||||
| Loans Payable Current | $0.00 | $0.00 | $8.7K | ||||||||||||||||||||
| Interest Payable Current | $450.00 | $450.00 | $450.00 | ||||||||||||||||||||
| Deferred Offering Costs | $0.00 | $5.3K | $8.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $172.2K | $23.2K | -$307.8K | -$182.8K | -$29.4K | -$7.7K |
| Net Cash Provided By Used In Financing Activities | -$115.9K | $646.1K | $315.5K | $194.2K | $10.8K | $28.3K |
| Proceeds From Related Party Debt | $3.0M | $962.8K | $614.0K | $178.7K | $2.9K | $7.1K |
| Increase Decrease In Accounts Payable | -$2.0K | $551.00 | -$7.6K | $0.00 | $0.00 | |
| Proceeds From Issuance Of Common Stock | $0.00 | $755.0K | $265.0K | $150.0K | $0.00 | $26.6K |
| Increase Decrease In Prepaid Expense | $16.5K | $4.8K | $0.00 | -$4.3K | $4.3K | $0.00 |
| Net Cash Provided By Used In Investing Activities | -$56.9K | -$26.0K | $0.00 | $0.00 | $0.00 | |
| Increase Decrease In Inventories | $278.0K | $20.6K | $25.4K | $12.3K | ||
| Increase Decrease In Accounts Receivable | $299.0K | $63.8K | $28.7K | $7.8K | ||
| Increase Decrease In Accrued Liabilities | $2.0K | $4.5K | $1.5K | $3.4K | ||
| Increase Decrease In Deferred Revenue | $112.3K | $20.4K | $3.9K | $0.00 | ||
| Proceeds From Issuance Of Preferred Stock And Preference Stock | $100.0K | $0.00 | ||||
| Proceeds From Payments For Other Financing Activities | $0.00 | $8.8K | $0.00 | |||
| Payments To Acquire Intangible Assets | $56.9K | $26.0K | $0.00 | |||
| Proceeds From Notes Payable | $0.00 | $7.1K | $0.00 | |||
| Allocated Share Based Compensation Expense | $0.00 | $225.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q1 2022 | Q4 2021 | Q4 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $328.3K | -$48.0K | -$66.7K | -$27.9K | -$949.00 | -$5.9K | -$578.00 | -$6.1K | -$2.8K | ||||
| Net Cash Provided By Used In Financing Activities | $67.5K | $121.7K | $64.6K | $40.0K | $1.9K | $100.0K | $0.00 | $6.1K | $2.8K | ||||
| Proceeds From Related Party Debt | $589.5K | $232.8K | $73.7K | $1.9K | $0.00 | $6.1K | $0.00 | ||||||
| Increase Decrease In Accounts Payable | $8.2K | -$3.4K | $1.9K | $1.0K | $0.00 | $3.9K | $0.00 | ||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $175.0K | $125.0K | $175.0K | $120.0K | $120.0K | $0.00 | $2.8K | |||||
| Increase Decrease In Prepaid Expense | -$3.4K | $0.00 | $0.00 | -$4.3K | $0.00 | ||||||||
| Net Cash Provided By Used In Investing Activities | -$30.0K | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Increase Decrease In Inventories | $157.4K | $2.7K | $1.8K | $734.00 | |||||||||
| Increase Decrease In Accounts Receivable | -$6.8K | -$15.0K | -$3.9K | $279.00 | |||||||||
| Increase Decrease In Accrued Liabilities | $14.8K | $445.00 | $0.00 | $5.0K | $0.00 | ||||||||
| Increase Decrease In Deferred Revenue | $25.7K | -$3.9K | $0.00 | ||||||||||
| Proceeds From Issuance Of Preferred Stock And Preference Stock | $40.0K | $100.0K | $0.00 | ||||||||||
| Proceeds From Payments For Other Financing Activities | $0.00 | $8.8K | $0.00 | ||||||||||
| Payments To Acquire Intangible Assets | $30.0K | $0.00 | |||||||||||
| Proceeds From Notes Payable | $0.00 | ||||||||||||
| Allocated Share Based Compensation Expense | $0.00 | $225.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.06 | $0.01 | -$0.01 | $0.00 | $0.00 | ||
| Common Stock Shares Outstanding | 11.0M | 11.0M | 40.9M | 5.5M | 5.5M | 5.5M | 2.8M |
| Common Stock Shares Issued | 11.0M | 11.0M | 40.9M | 5.5M | 5.5M | 5.5M | 2.8M |
| Common Stock Shares Authorized | 250.0M | 250.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 140.0K | 140.0K | 140.0K | 140.0K | 0.00 | ||
| Preferred Stock Shares Issued | 140.0K | 140.0K | 140.0K | 140.0K | 0.00 | ||
| Weighted Average Shares Outstanding Basic And Diluted | 33.8M | 4.7M | 5.5M | ||||
| Net Loss Per Share Basic And Diluted | $-0.01 | $-0.04 | $0.00 | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 11.0M | 10.5M | 33.8M | ||||
| Earnings Per Share Basic | $0.06 | $0.01 | $-0.01 | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 11.4M | 10.9M | 33.8M | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 5.5M | 3.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.01 | $0.01 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Common Stock Shares Outstanding | 11.0M | 43.9M | 43.9M | 42.1M | 41.6M | 41.6M | 40.8M | 40.3M | 39.8M | 5.5M | 5.5M | 5.5M | 5.5M | 5.5M | 5.5M | 5.5M | 5.5M | 5.5M | 3.1M | 2.8M | |
| Common Stock Shares Issued | 11.0M | 43.9M | 43.9M | 42.1M | 41.6M | 41.6M | 40.8M | 40.3M | 39.8M | 5.5M | 5.5M | 5.5M | 5.5M | 5.5M | 5.5M | 5.5M | 5.5M | 5.5M | 3.1M | 2.8M | |
| Common Stock Shares Authorized | 250.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 140.0K | 140.0K | 140.0K | 140.0K | 140.0K | 140.0K | 140.0K | 140.0K | 140.0K | 140.0K | 100.0K | 100.0K | 100.0K | 100.0K | |||||||
| Preferred Stock Shares Issued | 140.0K | 140.0K | 140.0K | 140.0K | 140.0K | 140.0K | 140.0K | 140.0K | 140.0K | 140.0K | 100.0K | 100.0K | 100.0K | 100.0K | |||||||
| Weighted Average Shares Outstanding Basic And Diluted | 41.6M | 41.4M | 40.4M | 39.8M | 13.9M | 5.5M | 9.4M | 9.4M | 2.9M | 5.5M | 5.5M | 5.5M | |||||||||
| Net Loss Per Share Basic And Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $-0.01 | $-0.01 | $-0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 11.0M | 43.9M | 43.9M | 10.5M | 41.6M | 41.4M | 40.4M | 5.5M | 5.5M | ||||||||||||
| Earnings Per Share Basic | $0.00 | $0.01 | $0.01 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 11.0M | 44.3M | 44.3M | 10.9M | 42.0M | 41.4M | 40.4M | ||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 5.5M | 5.5M | 5.5M | 4.1M | 2.9M | 2.8M | 2.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $1.2M | $1.2M | $417.2K | $158.8K | $20.9K | $20.9K | $2.5K |
| Interest Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Professional Fees | $315.2K | $75.5K | $29.7K | $78.8K | |||
| Stock Issued During Period Value New Issues | $755.0K | $265.0K | $150.0K | $28.0K | $26.6K | ||
| Stock Issued During Period Shares New Issues | 755.0K | 1.1M | 159.1K | 2.8M | |||
| Prepaid Expense Current | $21.3K | $4.8K | $0.00 | $0.00 | $4.3K | ||
| Due To Related Parties Current | $0.00 | $2.9K | $7.1K | $0.00 | |||
| Stock Issued During Period Value Other | -$3.1K | ||||||
| Payment Of Financing And Stock Issuance Costs | $0.00 | $6.1K | |||||
| Stock Issued During Period Shares Other | 34.4M | ||||||
| Issuance Of Stock And Warrants For Services Or Claims | $0.00 | $4.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $1.2M | $1.2M | $1.2M | $717.1K | $592.2K | $592.2K | $394.2K | $274.3K | $154.3K | $171.2K | $131.2K | $120.8K | $120.8K | $120.8K | $20.9K | $20.9K | $20.9K | $20.9K | $2.5K | $2.5K | |
| Interest Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Professional Fees | $130.4K | $76.7K | $35.8K | $23.3K | $13.5K | $9.9K | $7.2K | $6.5K | $6.0K | $7.0K | $500.00 | $4.3K | |||||||||
| Stock Issued During Period Value New Issues | $125.0K | $175.0K | $120.0K | $120.0K | $50.0K | $100.0K | $23.9K | $2.7K | |||||||||||||
| Stock Issued During Period Shares New Issues | 500.0K | 500.0K | 700.0K | 480.0K | 480.0K | 53.0K | 0.00 | 0.00 | |||||||||||||
| Prepaid Expense Current | $34.9K | $47.3K | $1.4K | $1.4K | $1.4K | $1.0K | $0.00 | $0.00 | $0.00 | ||||||||||||
| Due To Related Parties Current | $2.9K | $2.9K | $2.9K | $8.3K | $7.1K | $7.1K | $6.4K | $6.2K | $6.1K | ||||||||||||
| Stock Issued During Period Value Other | $125.0K | $175.0K | -$1.1K | $2.8K | |||||||||||||||||
| Payment Of Financing And Stock Issuance Costs | $0.00 | ||||||||||||||||||||
| Stock Issued During Period Shares Other | 34.4M | ||||||||||||||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $0.00 | $4.1K |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.